Abstract
Family history of breast cancer is an established risk factor for breast cancer. In addition, there is evidence that oral contraceptive use may be associated with a moderate increase in breast cancer risk. The three cohort studies that have investigated the relationship between oral contraceptive use and breast cancer risk among women with a family history of breast cancer have yielded mixed results, possibly due to the relatively small sample sizes employed and/or differences in the selection of covariates for inclusion in multivariate models. Therefore, we examined the association between oral contraceptive use and breast cancer risk in a large cohort study in Canada. The cohort consisted of the 27,318 women in the Canadian National Breast Screening Study who reported a family history of breast cancer on enrolment into the study. Linkages to national mortality and cancer databases yielded data on deaths and cancer incidence, with follow-up ending between 1998 and 2000, depending upon the province. During a mean of 16.0 years of follow-up, we observed 1707 incident cases of breast cancer among women with any history of breast cancer of which 795 cases occurred among women with a mother, sister, and/or daughter with breast cancer. Among women with any family history of breast cancer, ever use of oral contraceptives was associated with a 12% reduction in risk of breast cancer (95% confidence interval [CI]=0.73–1.07), and there was an inverse trend with increasing duration of use of borderline statistical significance (ptrend=0.03). Although we also observed a 25% lower risk of breast cancer associated with oral contraceptive use of greater than 84 months versus never use among women with a first degree relative with breast cancer, this finding was not statistically significant (95% CI=0.47–1.19, ptrend=0.48). Our data raise the possibility that relatively long duration of oral contraceptive use may be inversely associated with risk among women with a family history of breast cancer.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
SE Hankinson DJ Hunter (2002) Breast Cancer HO Adami DJ Hunter D Tricholopoulos (Eds) Textbook of Cancer Epidemiology Oxford University Press Oxford 301–339
Collaborative Group on Hormonal Factors in Breast Cancer (1996) Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Lancet 347: 1713–1727
SC Rubin (1998) ArticleTitleChemoprevention of hereditary ovarian cancer N Engl J Med 339 469–174 Occurrence Handle10.1056/NEJM199808133390710 Occurrence Handle9700183
SA Narod H Risch R Molsleh et al. (1998) ArticleTitleOral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group N Engl J Med 339 424–428 Occurrence Handle10.1056/NEJM199808133390702 Occurrence Handle9700175
SA Narod MP Dube J Klijn et al. (2002) ArticleTitleOral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers J Natl Cancer Inst 94 1773–1779
G Ursin BE Henderson RW Haile et al. (1997) ArticleTitleDoes oral contraceptive use increase the risk of breast cancer in women with BRCA1/BRCA2 mutations more than in other women Cancer Res 57 3678–3681 Occurrence Handle9288771
RJ Lipnick JE Buring CH Hennekens et al. (1986) ArticleTitleOral contraceptives and breast cancer: a prospective cohort study J Am Med Assoc 255 58–61 Occurrence Handle10.1001/jama.255.1.58
GA Colditz B Rosner FE Speizer (1996) ArticleTitleRisk factors for breast cancer according to family history of breast cancer J Natl Cancer Inst 88 365–371 Occurrence Handle8609646
DM Grabrick LC Hartmann JR Cerhan et al. (2000) ArticleTitleRisk of breast cancer with oral contraceptive use in women with a family history of breast cancer J Am Med Assoc 284 1791–1798 Occurrence Handle10.1001/jama.284.14.1791
PD Terry AB Miller JG Jones TE Rohan (2003) ArticleTitleCigarette smoking and the risk of invasive epithelial ovarian cancer in a prospective cohort study Eur J Cancer 39 1157–1164 Occurrence Handle10.1016/S0959-8049(03)00195-3 Occurrence Handle12736118
AB Miller CJ Baines T To C Wall (1992) ArticleTitleCanadian National Breast Screening Study. I. Breast cancer detection and death rates among women aged 40–49 years. II. Breast cancer detection and death rates among women aged 50–59 years Can Med Assoc J 147 1459–1488
KJ Rothman S Greenland (1998) Modern Epidemiology EditionNumber2 Lippincott-Raven Philadelphia (PA)
RL Milne JA Knight EM John et al. (2005) ArticleTitleRegistry ftBCF. Oral contraceptive use and risk of early-onset breast cancer in carriers and non-carriers of BRCA1 and BRCA2 mutations Cancer Epidemiol Biomarkers Prev. 14 350–356 Occurrence Handle10.1158/1055-9965.EPI-04-0376 Occurrence Handle15734957
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Silvera, S.A.N., Miller, A.B. & Rohan, T.E. Oral Contraceptive Use and Risk of Breast Cancer among Women with a Family History of Breast Cancer: a Prospective Cohort Study. Cancer Causes Control 16, 1059–1063 (2005). https://doi.org/10.1007/s10552-005-0343-1
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10552-005-0343-1